Literature DB >> 21221279

Multiple Sclerosis and its Management: The multidisciplinary team approach to management.

B Weinshenker.   

Abstract

Multiple sclerosis, the most common disabling disease of the central nervous system affecting young adults, is diagnosed primarily from a history of typical relapsing and remitting white matter symptoms supported by objective signs. Multiple sclerosis may present in more insidious ways or may be mimicked by other diseases, which seemingly satisfy the diagnostic criteria of dissemination in time and space. Patients need psychological support to deal with an uncertain future. A multidisciplinary team approach can best manage both acute temporary disability and, often later, progressive physical and occasionally mental disability.

Entities:  

Year:  1992        PMID: 21221279      PMCID: PMC2145472     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

1.  Cause of death in patients attending multiple sclerosis clinics.

Authors:  A D Sadovnick; K Eisen; G C Ebers; D W Paty
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

2.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.

Authors:  B G Weinshenker; B Bass; G P Rice; J Noseworthy; W Carriere; J Baskerville; G C Ebers
Journal:  Brain       Date:  1989-02       Impact factor: 13.501

Review 3.  The natural history of multiple sclerosis.

Authors:  B G Weinshenker; G C Ebers
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

4.  Multiple sclerosis: updated risks for relatives.

Authors:  A D Sadovnick; P A Baird; R H Ward
Journal:  Am J Med Genet       Date:  1988-03

5.  Double-blind study of benzydamine hydrochloride, a new treatment for sore throat.

Authors:  J F Wethington
Journal:  Clin Ther       Date:  1985       Impact factor: 3.393

6.  A controlled study of benzydamine oral rinse ("Difflam") in general practice.

Authors:  M W Whiteside
Journal:  Curr Med Res Opin       Date:  1982       Impact factor: 2.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.